These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7438184)

  • 41. [Are there any variations in the rate of detection of HBsAg in blood donors in the course of years? (author's transl)].
    Petz J; Rocková R
    Cas Lek Cesk; 1982 Apr; 121(15):470-2. PubMed ID: 7083293
    [No Abstract]   [Full Text] [Related]  

  • 42. [Incidence and dynamics of circulating immune complexes in acute viral hepatitis HBsAg positive and negative (author's transl)].
    Pintera J; Jezek P; Horecká J; Krajcová M
    Cas Lek Cesk; 1981 Apr; 120(17):513-7. PubMed ID: 7237498
    [No Abstract]   [Full Text] [Related]  

  • 43. [Circulating immune complexes in familial Mediterranean fever, systemic lupus erythematosus and HBsAg carriers].
    Zlotnick A; Levo Y; Fishel R; Ehrenfeld M; Levy M; Shouval D; Eliakin M
    Harefuah; 1979 Aug; 97(3-4):55-7. PubMed ID: 540822
    [No Abstract]   [Full Text] [Related]  

  • 44. [Detection of HBs antigen in blood donors by electroimmunoprecipitation and passive hemagglutination methods].
    Górska R; Sieradzki W; Kołodziejczyk M
    Wiad Lek; 1984 Mar; 37(6):430-3. PubMed ID: 6485326
    [No Abstract]   [Full Text] [Related]  

  • 45. Quantitative assay of hepatitis B surface antigen and DNA polymerase activity.
    Heijtink RA; Schalm SW
    N Engl J Med; 1979 Jul; 301(3):165. PubMed ID: 449970
    [No Abstract]   [Full Text] [Related]  

  • 46. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Importance of luminescence microscopic, immunological and morphological examinations in interpreting the structure of the HBs-antigen carrier state].
    Podlevskiĭ AF; Evdokimova TV; Maslova LA; Skorina AD
    Klin Med (Mosk); 1982 Feb; 60(2):75-8. PubMed ID: 6978430
    [No Abstract]   [Full Text] [Related]  

  • 48. [Circulating immune complexes in viral hepatitis B and cellular immunity].
    Belozerov ES; Makarova TA
    Klin Med (Mosk); 1983 Feb; 61(2):71-4. PubMed ID: 6601740
    [No Abstract]   [Full Text] [Related]  

  • 49. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B; Mühlbacher A; Melchior W
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain-Barré syndrome.
    Penner E; Maida E; Mamoli B; Gangl A
    Gastroenterology; 1982 Mar; 82(3):576-80. PubMed ID: 7054050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Value of the cytogenetic studies in the diagnosis of hepatitis B surface antigen carrier state].
    Frolov AF; Khersonskaia RIa; Diadiun ST; Rogotskaia LT
    Vrach Delo; 1981 Oct; (10):115-8. PubMed ID: 7303565
    [No Abstract]   [Full Text] [Related]  

  • 53. Australia antigen survey in Hungary. I. Healthy blood donors.
    Novák E; Hollós I; Penke S; Köszeghy S; Villányi P; Farkas E
    Acta Microbiol Acad Sci Hung; 1972; 19(1):29-37. PubMed ID: 4631213
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term prognosis of HBsAg positive hepatopathy.
    Seidlová V
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():287-98. PubMed ID: 2949508
    [No Abstract]   [Full Text] [Related]  

  • 55. A survey and follow-up study of anicteric hepatitis, other asymptomatic liver diseases and hepatitis B surface antigen carriers.
    Sung JL; Shih PL; Liaw YF; Lin WS; Tai TY; Hsieh SC; Wang CY; Chang CK; Wang TH; Yü JY; Chen JS
    Taiwan Yi Xue Hui Za Zhi; 1979 May; 78(5):452-9. PubMed ID: 288839
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage.
    Mendy ME; Fortuin M; Hall AJ; Jack AD; Whittle HC
    Br J Biomed Sci; 1999; 56(1):34-8. PubMed ID: 10492913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Circulating immune complexes and function of the T- and B-links of the immunity system of viral hepatitis B patients].
    Mitchenko IK; Bordonos VG; Degtiarenko OM; Kuiun LA; Afonina GB
    Vrach Delo; 1987 Aug; (8):119-20. PubMed ID: 3500542
    [No Abstract]   [Full Text] [Related]  

  • 58. [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal].
    Dieye A; Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L
    Dakar Med; 1999; 44(2):166-70. PubMed ID: 11957279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of a rapid test info immunochomatographic for detection of hepatitis B surface].
    Martínez-Lamas L; Rodríguez JJ; Regueiro BJ; Aguilera A
    Rev Esp Quimioter; 2011 Sep; 24(3):164-5. PubMed ID: 21947100
    [No Abstract]   [Full Text] [Related]  

  • 60. The need and value of routine screening of all pregnant women for hepatitis B surface antigen.
    Capar M; Kosić-Andrasević V; Popić G; Raguz L; Mahuĺja-Stamenković V; Zuzek A; Dujmović A; Milevoj-Razem M; Ljutić S
    Acta Med Croatica; 1995; 49(4-5):161-4. PubMed ID: 8630446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.